Results 111 to 120 of about 951,850 (217)
mm-Wave Substrate-Integrated Fabry-Perot/Leaky-Wave Antennas in E-Band. [PDF]
Bilal RMH +4 more
europepmc +1 more source
Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis
This schematic outlines the workflow from biomarker identification to duplex MethyLight assay validation for epithelial ovarian cancer diagnosis using cfDNA‐based liquid biopsy. Initial screening of hypermethylated CpG candidates (cg02957270, cg10061138 cg00480298, COL2A1) was performed in tissue using ARMS‐PCR, COBRA, qPCR and image analysis. Selected
Deepa Bisht +3 more
wiley +1 more source
Design of a Low-Cost Flat E-Band Down-Converter with Variable Conversion Gain. [PDF]
Harifi-Mood M +5 more
europepmc +1 more source
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski +12 more
wiley +1 more source
A Back-to-Back Gap Waveguide-Based Packaging Structure for E-Band Radio Frequency Front-End. [PDF]
Xiu T, Li Z, Wang L, Lin P.
europepmc +1 more source
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim +3 more
wiley +1 more source
High gain and wideband hybrid optical amplifier using bismuth-doped and neodymium-doped fibers for E-band applications. [PDF]
Donodin A, Kiani L, Noor S, Forysiak W.
europepmc +1 more source
An optimized DCO with modified binary-weighted DCTLs based hybrid tuning banks for an E-band DPLL. [PDF]
Tang L +6 more
europepmc +1 more source
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington +10 more
wiley +1 more source
Deutsche Comicforschung Band 1 (2005) - E. Sackmann (Hrsg.)
Ribbens, Kees
doaj +1 more source

